Through Indivumed’s state-of-the-art commercial research laboratory, extensive tumor biopsy collection, our direct clinical access to patients, and our biobank – controlled for pre-analytical variables – we are able to facilitate the development of personalized medicines to meet all your oncology laboratory needs.
Our laboratory team is made up of authorities in assay development and biomarker validation, applying cutting-edge genomic and proteomic expertise to guide our support of your research project. By utilizing our comprehensive range of techniques, training, and capability, you can rest safe in the knowledge that you are getting the very best services available to produce the most transformative research results.
In cancer, every cell has its own pattern of active genes and proteins, making for a highly complex disease.
As such, the evaluation of tumor heterogeneity and similarities within a tumor and across different cancer types is essential for the design of effectively stratified treatments – and thus additionally for the discovery of new therapeutic agents. In order to achieve a better diagnosis and staging of cancer on an individual basis, molecular tumor profiling for different biomarkers of a tissue sample is crucial.
To this end, Indivumed offers a variety of highly sensitive technologies for tumor profiling, including both genomic and proteomic analysis. Small amounts of tissue, which reflect the size of needle biopsies, can be processed in a standardized manner for different applications. The close interaction of different departments and their capabilities – including tissue handling, pathological analysis, proteomics, and genomics – together with the world’s highest quality biobank ensure maximum efficiency and quality. All processes run under ISO 9001:2015 and according to GCLP guidelines.
The tumor-profiling portfolio includes:
- (Phospho) Protein Profiling
- Laser Capture Microdissection
- Mutation Analysis
- Gene Expression Analysis